Aoyuan Healthy Life Group Company Limited

HKEX:3662.HK

0.55 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Revenue 388.235388.235393.27393.27391.584391.584423.292423.292468.93468.93501.944501.944430.599430.599274.172274.172254.42254.42195.981195.981175.914175.609133.656133.656156.501
Cost of Revenue 290.073290.073291.622291.622314.573314.573301.696301.696408.018408.018328.068328.068299.667299.667163.695163.695163.444163.444118.429118.429108.17131.32685.29385.293117.281
Gross Profit 98.16398.163101.648101.64877.01177.011121.597121.59760.91260.912173.876173.876130.932130.932110.477110.47790.97690.97677.55277.55267.74444.28348.36348.36339.22
Gross Profit Ratio 0.2530.2530.2580.2580.1970.1970.2870.2870.130.130.3460.3460.3040.3040.4030.4030.3580.3580.3960.3960.3850.2520.3620.3620.251
Reseach & Development Expenses 000000000000000000001.40000
General & Administrative Expenses 31.79631.79632.54232.54230.27130.27152.49952.49946.66346.66346.25446.25443.19243.19229.57829.57838.37538.37522.94222.94278.791-17.00718.11318.1136.609
Selling & Marketing Expenses 0.4920.4920.1380.1380.4510.4510.1970.1971.4671.4671.4121.4120.8430.8430.3310.3310.5470.5470.6880.6880.7130.3070.1560.1560.272
SG&A 36.45836.45875.15675.15627.66527.665104.104104.104187.237187.23755.48855.48852.95952.95931.79431.79441.78741.78724.20924.20979.504-16.718.71318.7136.881
Other Expenses 00000000000000000000-36.3736.370016.095
Operating Expenses 48.1748.1759.759.79.1999.19985.57885.578264.801264.80147.747.743.08343.08328.40628.40639.68739.68720.77920.77943.13419.6721.96521.96522.976
Operating Income 61.70561.70526.49226.49249.34749.34717.49317.493-126.325-126.325118.388118.38877.97377.97378.68378.68349.18949.18953.34353.34324.09531.43929.6529.6516.334
Operating Income Ratio 0.1590.1590.0670.0670.1260.1260.0410.041-0.269-0.2690.2360.2360.1810.1810.2870.2870.1930.1930.2720.2720.1370.1790.2220.2220.104
Total Other Income Expenses Net -8.167-8.16717.2617.2618.85918.85914.10114.101-81.37-81.372.1642.1645.225.220.9040.9042.3172.3174.4594.4591.097-1.108-3.164-3.164-0.311
Income Before Tax 53.53853.53843.75243.75268.20668.20631.59431.594-207.695-207.695120.552120.55283.19283.19279.58679.58651.50651.50657.80157.80125.19230.33126.48626.48616.023
Income Before Tax Ratio 0.1380.1380.1110.1110.1740.1740.0750.075-0.443-0.4430.240.240.1930.1930.290.290.2020.2020.2950.2950.1430.1730.1980.1980.102
Income Tax Expense 13.29413.2949.3919.39112.49112.4915.7275.72716.06916.06927.56927.56912.52512.52523.77523.77514.97614.97612.77612.7765.9826.9148.6728.6725.69
Net Income 46.95946.95931.6131.6155.48255.48224.72224.722-184.531-184.53189.06189.06169.65169.65155.52255.52236.26936.26944.97144.97119.14523.28317.85817.85810.278
Net Income Ratio 0.1210.1210.080.080.1420.1420.0580.058-0.394-0.3940.1770.1770.1620.1620.2030.2030.1430.1430.2290.2290.1090.1330.1340.1340.066
EPS 0.0650.0650.0440.0440.0760.0760.0340.034-0.25-0.250.120.120.0960.0960.0760.0770.050.050.070.070.0270.0330.0430.0430.015
EPS Diluted 0.0650.0650.0440.0440.0760.0760.0340.034-0.25-0.250.120.120.0960.0960.0770.0770.050.050.070.070.0270.0330.0430.0430.015
EBITDA 68.29468.29430.97830.97855.8155.8122.9822.98-118.677-118.677124.467124.46784.67384.67381.0181.0151.92251.92254.90254.90225.20232.43530.50730.50717.056
EBITDA Ratio 0.1760.1760.0790.0790.1430.1430.0540.054-0.253-0.2530.2480.2480.1970.1970.2950.2950.2040.2040.280.280.1430.1850.2280.2280.109